Insulinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of insulinoma include gender: woman, age:40-60 years, MEN1 syndrome, von Hippel | Common risk factors in the development of insulinoma include gender: woman, age:40-60 years, [[Multiple endocrine neoplasia type 1|MEN1]] syndrome, [[Von Hippel-Lindau Disease|von Hippel-Lindau]] disease, and [[Neurofibromatosis type I|Neurofibromatosis 1]] | ||
==Risk Factors== | ==Risk Factors== | ||
Line 13: | Line 13: | ||
**Gender: Females are more at risk of developing insulinoma than males | **Gender: Females are more at risk of developing insulinoma than males | ||
**Age: People who are in the age range of 40-60 years | **Age: People who are in the age range of 40-60 years | ||
**People with associated Multiple Endocrine Neoplasia type 1 syndrome(MEN 1)<ref name="pmid9735690">{{cite journal| author=Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH| title=Insulinoma--experience from 1950 to 1995. | journal=West J Med | year= 1998 | volume= 169 | issue= 2 | pages= 98-104 | pmid=9735690 | doi= | pmc=1305178 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9735690 }} </ref><ref name="pmid23742779">{{cite journal |vauthors=Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G |title=Risk factors for the occurrence of insulinoma: a case-control study |journal=HBPD INT |volume=12 |issue=3 |pages=324–8 |year=2013 |pmid=23742779 |doi= |url=}}</ref><ref name="urlInsulinoma - Health Encyclopedia - University of Rochester Medical Center">{{cite web |url=https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=134&contentid=219 |title=Insulinoma - Health Encyclopedia - University of Rochester Medical Center |format= |work= |accessdate=}}</ref> | **People with associated [[Multiple Endocrine Neoplasia type 1]] syndrome([[Multiple endocrine neoplasia type 1|MEN 1]])<ref name="pmid9735690">{{cite journal| author=Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH| title=Insulinoma--experience from 1950 to 1995. | journal=West J Med | year= 1998 | volume= 169 | issue= 2 | pages= 98-104 | pmid=9735690 | doi= | pmc=1305178 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9735690 }} </ref><ref name="pmid23742779">{{cite journal |vauthors=Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G |title=Risk factors for the occurrence of insulinoma: a case-control study |journal=HBPD INT |volume=12 |issue=3 |pages=324–8 |year=2013 |pmid=23742779 |doi= |url=}}</ref><ref name="urlInsulinoma - Health Encyclopedia - University of Rochester Medical Center">{{cite web |url=https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=134&contentid=219 |title=Insulinoma - Health Encyclopedia - University of Rochester Medical Center |format= |work= |accessdate=}}</ref> | ||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
*Less common risk factors in the development of insulinoma include: | *Less common risk factors in the development of insulinoma include: | ||
**Von Hippel | **[[Von Hippel-Lindau Disease|von Hippel-Lindau]] disease | ||
**Neurofibromatosis type 1<ref name="pmid23742779">{{cite journal |vauthors=Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G |title=Risk factors for the occurrence of insulinoma: a case-control study |journal=HBPD INT |volume=12 |issue=3 |pages=324–8 |year=2013 |pmid=23742779 |doi= |url=}}</ref><ref name="urlInsulinoma - Health Encyclopedia - University of Rochester Medical Center">{{cite web |url=https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=134&contentid=219 |title=Insulinoma - Health Encyclopedia - University of Rochester Medical Center |format= |work= |accessdate=}}</ref> | **[[Neurofibromatosis type I|Neurofibromatosis]] type 1<ref name="pmid23742779">{{cite journal |vauthors=Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G |title=Risk factors for the occurrence of insulinoma: a case-control study |journal=HBPD INT |volume=12 |issue=3 |pages=324–8 |year=2013 |pmid=23742779 |doi= |url=}}</ref><ref name="urlInsulinoma - Health Encyclopedia - University of Rochester Medical Center">{{cite web |url=https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=134&contentid=219 |title=Insulinoma - Health Encyclopedia - University of Rochester Medical Center |format= |work= |accessdate=}}</ref> | ||
==References== | ==References== |
Revision as of 18:05, 11 August 2017
Insulinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulinoma risk factors On the Web |
American Roentgen Ray Society Images of Insulinoma risk factors |
Risk calculators and risk factors for Insulinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Common risk factors in the development of insulinoma include gender: woman, age:40-60 years, MEN1 syndrome, von Hippel-Lindau disease, and Neurofibromatosis 1
Risk Factors
Common Risk Factors
- Common risk factors in the development of insulinoma include:
- Gender: Females are more at risk of developing insulinoma than males
- Age: People who are in the age range of 40-60 years
- People with associated Multiple Endocrine Neoplasia type 1 syndrome(MEN 1)[1][2][3]
Less Common Risk Factors
- Less common risk factors in the development of insulinoma include:
- von Hippel-Lindau disease
- Neurofibromatosis type 1[2][3]
References
- ↑ Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH (1998). "Insulinoma--experience from 1950 to 1995". West J Med. 169 (2): 98–104. PMC 1305178. PMID 9735690.
- ↑ 2.0 2.1 Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G (2013). "Risk factors for the occurrence of insulinoma: a case-control study". HBPD INT. 12 (3): 324–8. PMID 23742779.
- ↑ 3.0 3.1 "Insulinoma - Health Encyclopedia - University of Rochester Medical Center".